top of page
Projects
Hutchmed
....
Pharma Eyecare & Medical Aesthetics
A specialty eyecare pharmaceutical company embarked on a pivotal journey to expand its reach and redefine patient access. Having...
Global Oncology Biotech
The company faced a monumental challenge: scaling its operations to support the US sales expansion of very rare orphan drugs , while...
Egetis
....
Syndax
....
Scynexis
SCYNEXIS faced an extraordinary challenge: launching Brexafemme , a groundbreaking prescription oral treatment designed to eliminate the...
Calliditas
Callidatas US faced a formidable task: launching Nefecon, an orphan drug designed to treat the rare disease IgA Nephropathy (IgAN), in...
bottom of page